Skip to main content
Premium Trial:

Request an Annual Quote

LSBC Q2 Revenues Increased, But Under $1M

NEW YORK, July 23 - Large Scale Biology reported revenues of $0.9 million for the second quarter, compared to $490,000 in the same period last year.

 

The Vacaville, Calif., company had a net loss of $6.2 million for the quarter, compared to $9.6 million for the second quarter of 2002.

 

LSBC's R&D expenses narrowed to $2.8 million, from $5.9 million in the year-ago quarter. These expense reductions follow a restructuring program announced in June, in which the company plans to cut costs $5 million within the year. 

 

At the end of the second quarter, the company had $15.0 million in cash and marketable securities.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.